Lorrain Daniel S. bought CTNM
February 24, 2026 · Form 4 insider transaction
Lorrain Daniel S. bought 4,300 shares of Contineum Therapeutics, Inc. at $1.01 per share, a transaction worth $4.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,300
Price
$1.01
Total value
$4.3K
InsiderLorrain Daniel S.
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after160,352
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.